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Background Diabetes (DM) has important implications on LV remodeling and prognosis following acute myocardial infarction (MI). We explored the impact of diabetic heart disease independent of traditional risk factors, infarct size, and myocardial extracellular volume fraction (MECVF).
Methods
We prospectively studied 105 patients with acute MI from the ongoing PROSPECT-CMR clinical trial. Subjects underwent CMR 2 to 4 weeks following MI with follow-up scan at 6-months. Presence of diabetes was determined by history and laboratory testing. Total infarct size was calculated according to previously described full width half-maximum method. MECVF was quantified by serial sampling of T1 ratios of myocardium remote from infarct and blood pool corrected for hematocrit. Sampling was performed in 5-minute intervals beginning 5 minutes and ending 30 minutes after contrast administration from 3 parallel short-axis slices of the heart. Adverse remodeling was defined as a positive change in left ventricular diastolic volume index of greater than 10% at follow-up.
Results
Thirty-one patients (30%) had a history of type 2 diabetes mellitus (DM) preceding MI. Baseline characteristics and change in mean segmental MECVF are shown in Table 1 .
Unadjusted analysis of clinical and CMR characteristics, including change in mean segmental fibrotic index, revealed that only history of DM was associated with adverse remodeling (LR χ2 = 4.6). In multivariable logistic regression analysis, only history of DM remained significantly associated with adverse remodeling at 6 months (LR χ2 = 4.8) ( Figure 1 ). Change in total infarct size, mean segmental MECVF, and other baseline clinical characteristics, including LVEF, did not reach statistical significance. 
